Literature DB >> 10219992

Purification, characterization and anticoagulant activity of a proteolytic enzyme from Vespa orientalis venom.

B Haim1, A Rimon, J S Ishay, S Rimon.   

Abstract

The anticoagulant effect of Vespa orientalis venom sac extract (VSE) was attributed to a proteolytic process, involving mainly coagulation factors VIII and IX [Joshua, H., Ishay, J., 1975. Toxicon 13, 11-20; Korenberg et al., 1988. Toxicon 26, 1169-1176]. Preliminary purification of the proteolytic activity showed the presence of three separate proteases. One of which, protease I, was purified. The purified enzyme migrated as a double band on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE). The molecular weights of the bands, under reduced conditions were 42 and 44 kD. Both bands retained activity after the electrophoretic run. The enzyme hydrolyses bovine factor IX (BFIX), factor X (BFX) and prothrombin. The pH optimum for the degradation of BFIX was 7.0 and its isoelectric point is above pH 10. The amino acid composition of the protease was determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219992     DOI: 10.1016/s0041-0101(98)00218-9

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

1.  Terbium(III) fluorescence probe studies on metal ion-binding sites in anticoagulation factor I from Agkistrodon acutus venom.

Authors:  Xiaolong Xu; Qingliang Liu; Yi Liu; Yongshu Xie
Journal:  J Protein Chem       Date:  2002-02

Review 2.  Bioactive Peptides and Proteins from Wasp Venoms.

Authors:  Lei Luo; Peter Muiruri Kamau; Ren Lai
Journal:  Biomolecules       Date:  2022-03-30

3.  Biochemical and functional characterization of Parawixia bistriata spider venom with potential proteolytic and larvicidal activities.

Authors:  Gizeli S Gimenez; Antonio Coutinho-Neto; Anderson M Kayano; Rodrigo Simões-Silva; Frances Trindade; Alexandre de Almeida e Silva; Silvana Marcussi; Saulo L da Silva; Carla F C Fernandes; Juliana P Zuliani; Leonardo A Calderon; Andreimar M Soares; Rodrigo G Stábeli
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.